Investor's Business Daily102d agobearish
Drugmakers Climb On Q2 Reports, Even As One Misses Profit ViewsNews
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3125last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
InvestorsHub102d agobullish
Biogen Beats Second-Quarter Expectations as Growth Portfolio Drives Revenue HigherBioPharma Dive102d agoneutral
Earnings roundup: Biogen’s ‘resiliency,’ AstraZeneca’s growth pitch and GSK’s oncology pushInvesting.com102d agobullish
Biogen Q2 revenue, adjusted EPS beat estimates as growth portfolio lifts salesBarrons.com102d agoneutral
Biogen Raises Revenue Guidance as Growth Portfolio Outpaces Legacy Blockbuster DrugsStockStory103d agoneutral
Biogen (BIIB) Reports Q2: Everything You Need To Know Ahead Of EarningsClinical Trials Arena116d agobearish
AAIC26: Biogen stock drops after unveiling tau-targeting ASO dataSimply Wall St.117d agoneutral
Biogen (BIIB) Following Fresh Alzheimer’s Data Is The Upside Story Still IntactBarrons.com117d agoneutral
Biogen’s Alzheimer’s Drug Leaves Questions Unanswered, and That’s a Problem